Full Press Release Details
dupixent dupilumab late breaking phase 3 copd results presented at ats and simultaneously published in the new england journal of medicine.
REGN
dupixent dupilumab late breaking phase 3 copd results presented at ats and simultaneously published in the new england journal of medicine
Key Takeaway: dupixent dupilumab late breaking phase 3 copd results presented at ats and simultaneously published in the new england journal of medicine